Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 101–200 of 638
Xie, B., Wang, J., Xi, X., Guo, X., Chen, B.-X., Li, L., Hua, C., Zhao, S., Su, P., Chen, M., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05674-9 · Cited by 75
“According to MI-animal studies, cardiac fibroblast proliferation peaked from days 2 to 4 and declined through day 7, and the peak FAPI uptake was observed on day 6 after coronary ligation [11, 20].”
BackgroundResultFibroblast contributions to ischemic cardiac remodeling
Burke, R. M., Villar, K. N. B., & Small, E. M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109824 · Cited by 81
Adding insult to injury - Inflammation at the heart of cardiac fibrosis
Smolgovsky, S. A., Ibeh, U., Tamayo, T. P., & Alcaide, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109828 · Cited by 73
A coalition to heal—the impact of the cardiac microenvironment
Tzahor, E., & Dimmeler, S. (2022) · Science · doi:10.1126/science.abm4443 · Cited by 68
“Another cardiac fibroblast subtype, “matrifibrocytes,” which express genes typically observed in tendon, bone, and cartilage (14), was documented at later stages after injury.”
BackgroundHortells, L., Valiente-Alandí, Í., Thomas, Z. M., Agnew, E. J., Schnell, D. J., York, A. J., Vagnozzi, R. J., Meyer, E. C., Molkentin, J. D., & Yutzey, K. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009119117 · Cited by 73
Self-citationYamada, S., Ko, T., Hatsuse, S., Nomura, S., Zhang, B., Dai, Z., Inoue, S., Kubota, M., Sawami, K., Yamada, T., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00140-7 · Cited by 63
Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis
Odell, I. D., Steach, H. R., Gauld, S. B., Reinke-Breen, L., Kármán, J., Carr, T. L., Wetter, J. B., Phillips, L. A., Hinchcliff, M., & Flavell, R. A. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq6691 · Cited by 87
“A conceptually similar phenomenon of development vs maintenance may occur in long-term tissue remodeling and scar formation after myocardial infarction injury, in which lineage-traced myofibroblasts are retained in the scar but lose proliferative capacity and α SMA expression over time (81).”
Shi, Y., Yang, Y., Guo, Q., Gao, Q., Ding, Y., Wang, H., Xu, W., Yu, B., Wang, M., Zhao, Y., et al. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0242 · Cited by 67
“Fibroblasts are critical in the formation of fibrotic scar [3].”
Psarras, S., Beis, D., Nikouli, S., Tsikitis, M., & Capetanaki, Y. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00032 · Cited by 70
“Additional specialized fibroblast populations have been identified in the infarcted heart that may sustain ECM changes and pathology (96), again by analogy to what happens in other tissues.”
BackgroundLiu, X., Burke, R. M., Lighthouse, J. K., Baker, C. D., Dirkx, R. A., Kang, B., Chakraborty, Y., Mickelsen, D. M., Twardowski, J. J., Mello, S. S., et al. (2023) · Circulation Research · doi:10.1161/circresaha.121.320324 · Cited by 66
Li, R., & Frangogiannis, N. G. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.07.006 · Cited by 62
The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition
Glaser, S.-F., Heumüller, A. W., Tombor, L., Hofmann, P., Muhly-Reinholz, M., Fischer, A., Günther, S., Kokot, K. E., Okada, H., Hassel, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913481117 · Cited by 68
“While several studies suggested that EndMT contributes to cardiac fibrosis (11, 50, 62, 63), more recent lineage tracing studies suggest that repopulating fibroblasts mainly derive from preexisting fibroblasts and not from other sources (64)”
Yap Promotes Noncanonical Wnt Signals From Cardiomyocytes for Heart Regeneration
Liu, S., Tang, L., Zhao, X., Nguyen, B., Heallen, T. R., Li, M., Wang, J., Wang, J., & Martin, J. F. (2021) · Circulation Research · doi:10.1161/circresaha.121.318966 · Cited by 67
Zhang, S., Li, Y., Huang, X.-Z., Liu, K., Wang, Q.-D., Chen, A. F., Sun, K., Lui, K., & Zhou, B. (2021) · Circulation · doi:10.1161/circulationaha.121.055417 · Cited by 49
Fibroblast‐mediated intercellular crosstalk in the healthy and diseased heart
Nicin, L., Wagner, J. U. G., Luxán, G., & Dimmeler, S. (2021) · FEBS Letters · doi:10.1002/1873-3468.14234 · Cited by 79
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 75
Trogisch, F. A., Abouissa, A., Keles, M., Birke, A., Fuhrmann, M., Dittrich, G. M., Weinzierl, N., Wink, E., Cordero, J., Elsherbiny, A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.abq4581 · Cited by 60
An Improved Method of Maintaining Primary Murine Cardiac Fibroblasts in Two-Dimensional Cell Culture
Landry, N. M., Rattan, S. G., & Dixon, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-49285-9 · Cited by 76
The spatial and temporal activation of macrophages during fibrosis
Behmoaras, J. V., Mulder, K., Ginhoux, F., & Petretto, E. G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01186-x · Cited by 86
“…(see the ‘myofibroblast’ nomenclature in view of fibroblast plasticity 163 , the distinction between myofibroblasts and matrifibrocytes 10,164 , the atlas of collagen-producing cells 165 ), pro-resolving fibroblasts 44,166 , prenatal fibroblast activation potentially favouring…”
Therapies to prevent post-infarction remodelling: From repair to regeneration
Contessotto, P., & Pandit, A. S. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120906 · Cited by 64
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Bowers, S., Meng, Q., & Molkentin, J. D. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00043-7 · Cited by 65
Self-citationCircadian Rhythms in Cardiovascular Metabolism
Lal, H., Verma, S. K., Wang, Y., Xie, M., & Young, M. E. (2024) · Circulation Research · doi:10.1161/circresaha.123.323520 · Cited by 73
“120,121 As with virtually all cells, stimulus-response coupling results in metabolism-dependent perturbations in fibroblast function.”
Background(2024) · doi:10.1007/s00395-024-01074-w · Cited by 59
The Mechanobiology of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease
Islam, S., Boström, K. I., Carlo, D. D., Simmons, C. A., Tintut, Y., Yao, Y., & Hsu, J. J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.734215 · Cited by 60
Ventricular Arrhythmias in Ischemic Cardiomyopathy—New Avenues for Mechanism-Guided Treatment
Amoni, M., Dries, E., Ingelaere, S., Vermoortele, D., Roderick, H. L., Claus, P., Willems, R., & Sipido, K. R. (2021) · Cells · doi:10.3390/cells10102629 · Cited by 69
“Recent work suggests that the fibroblasts differentiation and invasion of the scar and BZ exhibit a unique phenotype and temporal profile as well [128,129].”
BackgroundMBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing
Bugg, D., Bailey, L. R. J., Bretherton, R. C., Beach, K. E., Reichardt, I. M., Robeson, K. Z., Reese, A. C., Gunaje, J. J., Flint, G. V., DeForest, C. A., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.012 · Cited by 62
Umbarkar, P., Ejantkar, S., Tousif, S., & Lal, H. (2021) · Cells · doi:10.3390/cells10092412 · Cited by 61
“specialized phenotype (matrifibrocyte) and remain in the matured scar [14,16].”
BackgroundMacrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing
Fraccarollo, D., Thomas, S., Scholz, C. J., Hilfiker‐Kleiner, D., Galuppo, P., & Bauersachs, J. K. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.12162 · Cited by 58
Cardiac Fibrosis and Cardiac Fibroblast Lineage-Tracing: Recent Advances
Fu, X., Liu, Q., Li, C., Li, Y., & Wang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00416 · Cited by 62
Self-citationYamada, Y., Sadahiro, T., Nakano, K., Honda, S., Abe, Y., Akiyama, T., Fujita, R., Nakamura, M., Maeda, T., Kuze, Y., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067504 · Cited by 59
“8,10 Cardiac reprogramming can reverse profibrotic CF transition and thereby reduce fibrosis in MI. 14 In contrast, interstitial and perivascular fibrosis is slowly generated in HFpEF in response to chronic stress.”
Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction
Zhang, Q.-J., He, Y., Li, Y., Shen, H., Lin, L., Zhu, M., Wang, Z., Luo, X., Hill, J. A., Cao, D. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319482 · Cited by 56
Saleh, K. K., Xi, H., Switzler, C., Skuratovsky, E., Romero, M. A., Chien, P., Gibbs, D. E., Gane, L., Hicks, M. R., Spencer, M. J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105415 · Cited by 61
Alsereidi, F. R., Khashim, Z., Marzook, H., Gupta, A., Al-Rawi, A. M., Ramadan, M. M., & Saleh, M. A. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102524 · Cited by 66
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 68
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
Cardiac Fibroblasts and Myocardial Regeneration
Chen, W., Bian, W., Zhou, Y., & Zhang, J. J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.599928 · Cited by 65
“We found that the inhibition of myofibroblast cells derived from NMCCs could improve the efficacy of cardiac cell therapy (Gao et al., 2018).”
BackgroundBobowski-Gerard, M., Boulet, C., Zummo, F. P., Dubois-Chevalier, J., Gheeraert, C., Bou Saleh, M., Strub, J.-M., Farce, A., Ploton, M., Guille, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33063-9 · Cited by 51
Animal models to study cardiac regeneration
Weinberger, M., & Riley, P. R. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00914-x · Cited by 66
Kalyanasundaram, A., Li, N., Gardner, M. L., Artiga, E. J., Hansen, B. J., Webb, A., Freitas, M. A., Pietrzak, M., Whitson, B. A., Mokadam, N. A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051583 · Cited by 52
Contreras, O., Soliman, H. S., Théret, M., Rossi, F. M. V., & Brandan, E. (2020) · Journal of Cell Science · doi:10.1242/jcs.242297 · Cited by 54
Mouton, A. J., Flynn, E. R., Moak, S. P., Aitken, N. M., Omoto, A. C. M., Li, X., da Silva, A. A., Wang, Z., do Carmo, J. M., & Hall, J. E. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.05.008 · Cited by 53
Sun, C., Tian, X., Jia, Y., Yang, M., Li, Y., & Fernig, D. G. (2022) · Open Biology · doi:10.1098/rsob.210356 · Cited by 53
“collagen, elastin and fibronectin) and lysyl oxidase (LOX) [3,26].”
BackgroundCardiac Fibroblast to Myofibroblast Phenotype Conversion—An Unexploited Therapeutic Target
Czubryt, M. P. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6030028 · Cited by 56
“Eventually, myofibroblasts arise, but even this phenotype is not necessarily the final end-point, as these cells may undergo a subsequent senescence, exiting the cell cycle but persisting at the site of injury [10].”
BackgroundLong noncoding RNA Cfast regulates cardiac fibrosis
Zhang, F., Fu, X., Kataoka, M., Liu, N., Wang, Y., Gao, F., Liang, T., Dong, X., Pei, J., Hu, X., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.013 · Cited by 53
“Kyoto Encyclopedia of Genes andGenomes (KEGG)orGeneOntology (GO)pathwayanalyses revealed that oxidative phosphorylation, ECM-receptor interaction, cell proliferation, and inflammatory responseswere among the topdysregulated genes in MI hearts (Figures S1A and S1B), consistent with prior reports.(4,25) Interestingly, 2…”
ResultSelf-citationChen, Y., Younis, M. R., He, G., Zheng, Z., Wang, Y., Xue, K., Sun, J., Liu, K., Huang, P., & Wang, X. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300456 · Cited by 49
Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis
Smolgovsky, S. A., Theall, B. P., Wagner, N., & Alcaide, P. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00545.2023 · Cited by 52
Liao, Y., Li, H., Cao, H., Dong, Y., Gao, L., Liu, Z., Ge, J., & Zhu, H. (2020) · Protein & Cell · doi:10.1007/s13238-020-00750-6 · Cited by 48
Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues
Dooling, L. J., Saini, K., Anlaş, A. A., & Discher, D. E. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.06.006 · Cited by 46
Injectable Antioxidant and Oxygen-Releasing Lignin Composites to Promote Wound Healing
Balaji, S., Short, W. D., Padon, B. W., Belgodere, J. A., Jimenez, S. E., Deoli, N., Guidry, A. C., Green, J. C., Prajapati, T. J., Farouk, F., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c22982 · Cited by 48
Cardiac pericytes mediate the remodeling response to myocardial infarction
Quijada, P. J., Park, S., Zhao, P., Kolluri, K., Wong, D., Shih, K. D., Fang, K., Pezhouman, A., Wang, L., Daraei, A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162188 · Cited by 51
“Resident cardiac fibroblasts secrete large amounts of ECM 4–7 days after injury and lose their proliferative capacity by days 7–10 after MI (51).”
Abe, H., Tanada, Y., Omiya, S., Podaru, M., Murakawa, T., Ito, J., Shah, A. M., Conway, S. J., Ono, M., & Otsu, K. (2021) · Science Signaling · doi:10.1126/scisignal.abe4932 · Cited by 48
Fang, J., Zhang, Y., Chen, D., Zheng, Y., & Jiang, J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s377479 · Cited by 48
“Eventually, CFs return to the resting stage or stay in the matured scar with a specialized phenotype called matrifibrocyte after scar maturation.(16,17) Cardiac fibrosis is generally classified into three subtypes from the histopathological point of view, namely replacement fibrosis, interstitial fibrosis, and perivas…”
BackgroundScleraxis and fibrosis in the pressure-overloaded heart
Nagalingam, R. S., Chattopadhyaya, S., Al‐Hattab, D. S., Cheung, D. Y. C., Schwartz, L. Y., Jana, S., Aroutiounova, N., Ledingham, D. A., Moffatt, T. L., Landry, N. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac362 · Cited by 48
Sakamoto, T., & Kelly, D. P. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.12.008 · Cited by 53
Santos, G. L., Hartmann, S., Zimmermann, W., Ridley, A. J., & Lutz, S. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.015 · Cited by 52
The Roles of Noncardiomyocytes in Cardiac Remodeling
Yang, D., Liu, H., Liu, F.-Y., Tang, N., Guo, Z., Ma, S., An, P., Wang, M., Wu, H., Yang, Z., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47180 · Cited by 50
“5-fold; in the middle stage (days 4-7), CFs differentiated into myofibroblasts that secreted large amounts of ECM to maintain the integrity of the heart tissue; and finally (by day 10), these cells gradually lost the ability to proliferate and produce α-SMA and ultimately turned into matrifibrocytes during scar maturi…”
BackgroundConsequences of PDGFRα+ fibroblast reduction in adult murine hearts
Kuwabara, J. T., Hara, A., Bhutada, S., Gojanovich, G. S., Chen, J., Hokutan, K., Shettigar, V., Lee, A. Y.-C., DeAngelo, L. P., Heckl, J. R., et al. (2022) · eLife · doi:10.7554/elife.69854 · Cited by 50
“In response to cardiac injury, fibroblasts rapidly adopt an activated phenotype resulting in increased proliferation and deposition of a collagenrich ECM (Ivey et al., 2018; Christia et al., 2013; MooreMorris et al., 2014; Fu et al., 2018).”
BackgroundWang, B., Tan, Y., Zhang, Y., Zhang, S., Duan, X., Jiang, Y., Li, T., Zhou, Q., Liu, X., & Zhan, Z. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00904-y · Cited by 48
Mouton, A. J., Aitken, N. M., Moak, S. P., do Carmo, J. M., da Silva, A. A., Omoto, A. C. M., Li, X., Wang, Z., Schrimpe‐Rutledge, A. C., Codreanu, S. G., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1136252 · Cited by 50
The heterocellular heart: identities, interactions, and implications for cardiology
Lother, A., & Köhl, P. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01000-6 · Cited by 52
“In the context of cardiac lesion repair, up to four states have been suggested: resident fibroblast, activated fibroblast, myofibroblast, and matrifi-brocyte, all with distinct functional properties [56].”
BackgroundChanges in cardiac resident fibroblast physiology and phenotype in aging
Trial, J., & Cieslik, K. A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2018 · Cited by 49
Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells
Fernandes, I. M., Funakoshi, S., Hamidzada, H., Epelman, S., & Keller, G. M. (2023) · Nature Communications · doi:10.1038/s41467-023-43312-0 · Cited by 49
“The expression levels of genes indicative of activated fi broblasts (myo fi broblasts)suchas TNC,ACTA2 , PALLD ,and CNN1 as wellas those associated with transition to the matri fi brocyte state including CHAD, COMP , and CILP2 , were also upregulated in these fi broblasts 30 .”
Ke, D., Cao, M., Ni, J., Yuan, Y., Deng, J.-Y., Chen, S., Dai, X., & Zhou, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05353-x · Cited by 51
“This subcluster exhibits the characteristic of matrifibrocytes, which appeared late in the infarction phase as mentioned in the previous study, persisted in the scarred area, expressed the Comp gene, and lost αSMA expression (Figure S1A) [39,40].”
BackgroundResultLi, S., Sun, X., Wu, H., Yu, P., Wang, X., Jiang, Z., Gao, E., Chen, J., Li, D., Qiu, C., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6408352 · Cited by 43
“Three to seven days after MI injury, CFs transdifferentiate into CMFs that secrete an abundance of extracellular matrix proteins and express α-SMA to structurally support the necrotic area; α-SMA expression is maintained as the collagen-containing extracellular matrix and scar fully mature [35].”
BackgroundThe Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function
Levick, S. P., & Widiapradja, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030970 · Cited by 50
“This was recently demonstrated in myocardial ischemia where cardiac fibroblasts proliferate in the infarct/border zone region on days two to three, while converting to a myofibroblast phenotype on days three through 10 [39].”
BackgroundLeukocyte-Dependent Regulation of Cardiac Fibrosis
Okyere, A. D., & Tilley, D. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00301 · Cited by 43
Li, R., Chen, B., Kubota, A., Hanna, A., Humeres, C. D., Hernández, S. C., Liu, Y., Ma, R., Tuleta, I., Huang, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43369-x · Cited by 52
“Infarctmyo fi broblastdensityinhealinginfarctspeaks during the proliferative phase of cardiac repair 35,36 (7-day timepoint) and is signi fi cantly reduced as the scar matures (28-day timepoint), as myo fi broblasts become deactivated and convert to matri fi brocytes 37 .”
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice
Bongiovanni, C., Bueno-Levy, H., Pena, D. P., Bono, I. D., Miano, C., Boriati, S., Pra, S. D., Sacchi, F., Redaelli, S., Bergen, M. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114162 · Cited by 42
Streef, T. J., & Smits, A. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.750243 · Cited by 45
“MFCs were identified as cells that express high levels of ECM genes and support the integrity of the mature scar in injured hearts (165).”
BackgroundChen, B., Li, R., Kubota, A., Alex, L., & Frangogiannis, N. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-08278-x · Cited by 44
Smad-dependent pathways in the infarcted and failing heart
Humeres, C. D., Venugopal, H., & Frangogiannis, N. G. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102207 · Cited by 45
Kattih, B., Boeckling, F., Shumliakivska, M., Tombor, L., Rasper, T., Schmitz, K., Hoffmann, J., Nicin, L., Abplanalp, W. T., Carstens, D. C., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad140 · Cited by 45
Cardiac fibroblast diversity in health and disease
Soliman, H., & Rossi, F. M. V. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.003 · Cited by 39
Medzikovic, L., Aryan, L., Ruffenach, G., Li, M., Savalli, N., Sun, W., Sarji, S., Hong, J. S., Sharma, S., Olcese, R., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.168655 · Cited by 40
“CF activation, transition to profibrotic myofibroblasts (MF), and reversion to a quiescent state all modulate the onset and progression of the fibrotic response (13, 14).”
Aghagolzadeh, P., Plaisance, I., Bernasconi, R., Treibel, T. A., Pulido-Quetglas, C., Wyss, T., Wigger, L., Nemir, M., Sarre, A., Chouvardas, P., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062601 · Cited by 46
Egr1 regulates regenerative senescence and cardiac repair
Zhang, L., Elkahal, J., Wang, T., Rimmer, R., Genzelinakh, A., Bassat, E., Wang, J., Perez, D. E., Kain, D., Lendengolts, D., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00493-1 · Cited by 40
Dufeys, C., Daskalopoulos, E. P., Castanares‐Zapatero, D., Conway, S. J., Ginion, A., Bouzin, C., Ambroise, J., Bearzatto, B., Gala, J., Heymans, S. R. B., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00846-y · Cited by 44
Rodrigues, K. E., Pontes, M. H. B., Cantão, M. B. S., & do Prado, A. F. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107285 · Cited by 45
(Re) Solving Repair After Myocardial Infarction
Leoni, G., & Soehnlein, O. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01342 · Cited by 40
Hanna, A., Shinde, A. V., Li, R., Alex, L., Humeres, C. D., Balasubramanian, P., & Frangogiannis, N. G. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.05.005 · Cited by 39
Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
Delgado‐Valero, B., Cachofeiro, V., & Martínez‐Martínez, E. (2021) · Cells · doi:10.3390/cells10071824 · Cited by 42
“In addition, during the maturation phase, the activated fibroblasts go through apoptosis and senescence [115].”
BackgroundSKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
Landry, N. M., Rattan, S. G., Filomeno, K. L., Meier, T. W., Meier, S. C., Foran, S. J., Meier, C. F., Koleini, N., Fandrich, R. R., Kardami, E., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00865-9 · Cited by 40
“We next probed Tcf21, a marker of quiescent resident cardiac fibroblasts which has been shown to decrease in expression during fibrogenesis [17, 26].”
BackgroundXu, X., Hua, X., Han, M., Hu, S., & Song, J. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-022-00972-1 · Cited by 42
“During scar maturation, myoFBs differentiate into matrifibrocytes, promoting condensation of the collagen scar and increasing its complexity [55].”
Gil, H., Goldshtein, M., Etzion, S., Elyagon, S., Hadad, U., Etzion, Y., & Cohen, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-26035-y · Cited by 42
“Using the simple method of flow cytometry, we obtained a well-defined timeframe for periostin manipulation after MI, and we showed that it supports the four differentiated states of the fibroblast under scar formation proposed by Fu et al. 21 .”
Torimoto, K., Elliott, K., Nakayama, Y., Yanagisawa, H., & Eguchi, S. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae044 · Cited by 38
Heart Slice Culture System Reliably Demonstrates Clinical Drug-Related Cardiotoxicity
Miller, J. M., Meki, M., Ou, Q., George, S. A., Gams, A., Abouleisa, R., Tang, X., Ahern, B. M., Giridharan, G. A., El-Baz, A. S., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115213 · Cited by 44
Pericytes in the infarcted heart
Alex, L., & Frangogiannis, N. G. (2019) · Vascular Biology · doi:10.1530/vb-19-0007 · Cited by 37
Barbosa, D. M., Fahlbusch, P., de Wiza, D. H., Jacob, S., Kettel, U., Al‐Hasani, H., Krüger, M., Ouwens, D. M., Hartwig, S., Lehr, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61886-3 · Cited by 39
Han, X., Yang, Y., Zhang, M., Li, L., Xue, Y., Jia, Q., Wang, X., & Guan, S. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s386805 · Cited by 35
“During this process, the expression of α-SMA in the myocardium is increased.(7) The massive deposition of ECM and the decrease in the degradation of ECM lead to an imbalance and disturbance of the collagen structure, which eventually leads to MF.”
BackgroundThe Role of Exosomal Non-Coding RNAs in Coronary Artery Disease
Liu, J., Wu, J., Li, L., Li, T., & Wang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603104 · Cited by 34
“Fibroblasts play a key role in the formation of fibrous scars and are involved in different stages of heart tissue repair and play different roles (Fu et al., 2018).”
BackgroundA Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)
Kelly, J. M., Jeitner, T. M., Ponnala, S., Williams, C. M., Nikolopoulou, A., DiMagno, S. G., & Babich, J. W. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01593-1 · Cited by 35
Garbincius, J. F., Luongo, T. S., Jadiya, P., Hildebrand, A. N., Kolmetzky, D. W., Mangold, A. S., Roy, R., Ibetti, J., Nwokedi, M., Koch, W. J., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.001 · Cited by 37
Bernier, L., Hefendehl, J. K., Scott, R. W., Tung, L. W., Lewis, C. B., Soliman, H., Simm, S., Dissing‐Olesen, L., Hofmann, J. C., Guo, D., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01872-y · Cited by 43
“On the other hand, fibroblasts have repeatedly been shown to produce matrix components that lead to scar formation by activating a fibrogenic program after injury 15,74,75 .”
Can Myocardial Fibrosis Be Reversed?
Frangogiannis, N. G. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.094 · Cited by 34
“In a similar manner, following myocardial infarction, fibroblast populations undergo dramatic phenotypic changes, transitioning through proinflammatory and matrixsynthetic myofibroblast phenotypes, only to become quiescent or undergo apoptosis during the maturation phase of healing (11,12).”
BackgroundAckerman, J. E., Muscat, S. N., Adjei‐Sowah, E., Korcari, A., Nichols, A. E. C., Buckley, M. R., & Loiselle, A. E. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.12.004 · Cited by 37
Vascular Homeostasis and Inflammation in Health and Disease—Lessons from Single Cell Technologies
Bondareva, O., & Sheikh, B. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134688 · Cited by 34
“Scar formation is propagated via fibroblast activation modulated by periostin (Postn) and TGFβ-WNT signaling pathways, as well as fibroblast trans-differentiation into myofibroblasts, which is accompanied by the acquisition of SMC markers [65,66].”
BackgroundMullany, L. K., Rohira, A. D., Leach, J. P., Kim, J. H., Monroe, T. O., Ortiz, A. R., Stork, B. A., Gaber, M. W., Sarkar, P., Sikora, A. G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011614117 · Cited by 32
“The most highly enriched fibroblast population (CF-C) is marked by expression of the matrifibrocyte marker cartilage oligomeric matrix protein (COMP), previously suggested to have an important role in maintaining the structural integrity of post-MI scar tissue (23).”
Controlling cardiac fibrosis through fibroblast state space modulation
Reichardt, I. M., Robeson, K. Z., Regnier, M., & Davis, J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109888 · Cited by 36
“The disappearance of myofibroblasts over time via transdifferentiation, deactivation, and senescence suggests that the myofibroblast state is transient and likely unstable [2,4].”
BackgroundResultInfluentialGarvin, A. M., Both, M. D. D., Talboom, J. S., Lindsey, M. L., Huentelman, M. J., & Hale, T. M. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16352 · Cited by 35
Bachmann, J. C., Baumgart, S. J., Uryga, A., Bosteen, M. H., Borghetti, G., Nyberg, M., & Herum, K. M. (2022) · Cells · doi:10.3390/cells11101657 · Cited by 31
“Furthermore, a sophisticated lineage tracing study by the Molkentin lab described the dynamic differentiation path of CFs during the course of cardiac remodeling following MI [34].”
Background
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.